Michele Massimino

14PUBLICATIONS
32CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsHaematological tumoursCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 27, 2026
Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.

|Feb 27, 2026
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model.

Andrea Duminuco, Silvia Rita Vitale, Antonella Nardo

|Feb 12, 2026
Identification of Resistance Genes in Breast Cancer Cells Treated with Fulvestrant and Ribociclib via Retroviral Screening and Integration Site Sequencing.

Zhangzan Huang, Corine Beaufort, Jean Helmijr

|Dec 11, 2025
Chronic Myeloid Leukemia and the T315I BCR::ABL1 Mutation.

Federico Pierro, Stefania Stella, Manlio Fazio

|Jul 29, 2025
The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness.

Michele Massimino, Stefania Stella, Chiara Romano

|Mar 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

Fabio Stagno, Stefania Stella, Salvatore Leotta

Pageof 3

Frequent Collaborators

8 joint publications

Silvia Rita Vitale

6 joint publications

Cristina Tomarchio

5 joint publications

Stefania Stella

5 joint publications

Elena Tirrò